Recombinant Kogia breviceps NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L)

What is the function of MT-ND4L in the mitochondrial respiratory chain?

MT-ND4L serves as a core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). This protein is specifically part of the enzyme membrane arm embedded in the lipid bilayer and is critically involved in proton translocation. It works in conjunction with other subunits to catalyze electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor . The protein's hydrophobicity allows it to be properly embedded within the mitochondrial inner membrane, facilitating its role in the chemiosmotic process that ultimately leads to ATP production. Understanding this function is essential for researchers investigating mitochondrial respiratory chain disorders, bioenergetics, and evolutionary aspects of mitochondrial proteins.

How is MT-ND4L involved in Complex I assembly?

MT-ND4L is one of the hydrophobic proteins translated from mitochondrial DNA that becomes integrated into the membrane arm of Complex I during the assembly process . According to the assembly pathway model described in the research, MT-ND4L likely contributes to the formation of the membrane arm subassembly. The assembly of Complex I begins with the formation of a 315 kDa subcomplex anchored to the membrane by MT-ND1. Separately, a 370 kDa subcomplex consisting of subunits of the membrane arm (which likely includes MT-ND4L) is formed. These subcomplexes join together to create a 550 kDa intermediate. Upon addition of the most distal components of the membrane arm, including MT-ND4 and MT-ND5, an 815 kDa subassembly is formed . Understanding this assembly process is crucial for researchers investigating mitochondrial disorders related to Complex I deficiencies.

What expression systems are most effective for producing recombinant Kogia breviceps MT-ND4L?

For the expression of hydrophobic mitochondrial proteins like MT-ND4L, several systems can be employed with specific modifications to address the challenges of membrane protein expression:

• Bacterial expression systems: E. coli-based systems utilizing specialized strains (C41(DE3) or C43(DE3)) designed for membrane protein expression can be effective when optimized. Key considerations include:

  • Using fusion partners like MBP or SUMO to enhance solubility

  • Employing low induction temperatures (16-20°C)

  • Utilizing specialized detergents for extraction

• Eukaryotic expression systems: Yeast (S. cerevisiae or P. pastoris) or insect cell systems may provide better folding environments for mitochondrial proteins.

• Cell-free expression systems: These can be particularly useful for toxic membrane proteins and allow direct incorporation into liposomes or nanodiscs.

Researchers should optimize codon usage for the expression host and consider incorporating purification tags that can be removed without affecting the protein's native structure. Expression trials should systematically evaluate temperature, inducer concentration, and expression duration to maximize yield while maintaining protein functionality.

What purification strategies effectively isolate recombinant MT-ND4L while maintaining its structural integrity?

Purifying hydrophobic membrane proteins like MT-ND4L requires specialized approaches:

• Detergent selection: Initial screening of mild detergents (DDM, LMNG, or digitonin) is crucial to solubilize the protein while preserving structure.

• Purification workflow:

  • Initial capture using affinity chromatography (IMAC for His-tagged constructs)

  • Intermediate purification using ion exchange chromatography

  • Final polishing using size exclusion chromatography in detergent-containing buffers

• Stabilization approaches:

  • Incorporation into nanodiscs or amphipols for detergent-free handling

  • Addition of lipids from the native membrane environment

Throughout purification, researchers should monitor protein stability using methods such as thermal shift assays and limited proteolysis to ensure the structural integrity is maintained.

How can recombinant MT-ND4L be used to study Complex I assembly defects?

Recombinant MT-ND4L can serve as a valuable tool for investigating Complex I assembly defects through several experimental approaches:

• Reconstitution studies: Purified recombinant MT-ND4L can be used in in vitro reconstitution experiments to assess its integration into Complex I subcomplexes. This approach allows researchers to determine the specific role of MT-ND4L in the assembly process and identify interaction partners.

• Rescue experiments: In cell lines with MT-ND4L deficiencies or mutations, introduction of wild-type recombinant protein can help determine if assembly defects can be rescued. This is particularly relevant given the observation that mutations in Complex I components can lead to accumulation of subcomplexes of 815 kDa and 550 kDa .

• Interaction studies: Techniques such as co-immunoprecipitation or crosslinking mass spectrometry using recombinant MT-ND4L can identify direct interaction partners during assembly. The 550 kDa subcomplex that accumulates during assembly defects represents a critical intermediate where interactions can be studied .

• CRISPR/Cas9 replacement studies: Using gene editing to replace endogenous MT-ND4L with tagged or mutated versions can provide insights into assembly mechanisms in cellular contexts.

Researchers should utilize blue native PAGE (BN-PAGE) to monitor the formation of Complex I subcomplexes (550 kDa and 815 kDa) when studying assembly, similar to the approaches used in identifying the roles of assembly factors like NDUFAF1-4, ACAD9, ECSIT, FOXRED1, and TMEM126B .

What methods effectively assess the functional impact of MT-ND4L mutations?

To evaluate how mutations in MT-ND4L affect its function, researchers can employ several complementary approaches:

• Oxygen consumption measurements: Measuring cellular respiration rates can quantify the functional impact of MT-ND4L mutations on Complex I activity. Techniques such as high-resolution respirometry or oxygen consumption rate (OCR) measurements can be used, followed by substrate-specific analyses (adding duroquinol to bypass Complex I) to confirm Complex I-specific defects .

• Enzymatic activity assays: NADH:ubiquinone oxidoreductase activity assays using isolated mitochondria or purified complexes can directly measure the impact of mutations on electron transfer rates.

• Membrane potential measurements: Using potentiometric dyes like TMRM or JC-1 to assess if mutations affect the proton translocation function of MT-ND4L.

• Structural studies: Cryo-EM analyses of assembled complexes containing mutant MT-ND4L can identify structural aberrations that explain functional defects.

• Phosphorylation analysis: Given that cAMP-dependent phosphorylation has been shown to modulate Complex I activity , assessing phosphorylation state changes in mutant proteins may provide mechanistic insights.

Research has shown that mutations in Complex I components can have profound effects, including abolishing cAMP-dependent activation and causing assembly defects. For example, a 5 bp duplication that destroyed a phosphorylation site in NDUFS4 abolished cAMP-dependent activation of Complex I, while a nonsense mutation leading to protein termination caused assembly defects .

How do evolutionary variations in MT-ND4L across marine mammals impact Complex I function?

Evolutionary analysis of MT-ND4L across marine mammals reveals patterns of conservation and adaptation that can provide insights into Complex I function:

• Phylogenetic analysis: By comparing MT-ND4L sequences across marine mammals like Kogia breviceps (pygmy sperm whale) and other cetaceans, researchers can identify conserved regions crucial for function versus variable regions that may represent adaptive evolution. Molecular clock analyses similar to those performed on sperm whales (estimated TMRCA of 136.7 thousand years ago) can provide temporal context for these changes.

• Selection pressure analysis: Calculating dN/dS ratios across the MT-ND4L gene can identify regions under purifying or positive selection, potentially revealing functionally critical domains.

• Structure-function correlations: Mapping sequence variations onto structural models can identify if changes occur in functionally important regions like proton channels or ubiquinone binding sites.

• Biochemical characterization: Comparative analyses of Complex I activity from different species can determine if sequence variations correlate with functional differences in catalytic efficiency, oxygen affinity, or proton pumping capacity.

• Environmental adaptation: Correlating MT-ND4L variations with ecological parameters (dive depth, temperature ranges) can reveal adaptations specific to marine mammal bioenergetics.

Researchers should consider that marine mammals have undergone significant mitochondrial adaptations to accommodate their hypoxic diving lifestyle, potentially affecting Complex I components like MT-ND4L. Population genetic approaches, similar to the skyline and skygrid analyses mentioned for whale populations , can help identify if certain variants have undergone selective sweeps.

How can recombinant MT-ND4L be used to investigate mitochondrial disease mechanisms?

Recombinant MT-ND4L offers unique opportunities to investigate mitochondrial disease mechanisms through several sophisticated approaches:

• Patient mutation modeling: Introducing patient-derived mutations into recombinant Kogia breviceps MT-ND4L can create experimental models to study specific mitochondrial diseases. This approach parallels studies of NDUFS4 mutations associated with complex I deficiency and fatal neurological syndrome .

• Interspecies complementation: Evaluating whether MT-ND4L from different species can functionally complement deficiencies in human cells can reveal conserved disease mechanisms. The evolutionary distance between marine mammals and humans makes this particularly interesting.

• Tissue-specific effects: Expressing recombinant MT-ND4L in different cell types (neurons, muscle cells, fibroblasts) can help explain the tissue-specific manifestations of mitochondrial diseases. Research has shown that fibroblast and myoblast cultures exhibit distinct responses to cAMP-dependent phosphorylation of Complex I components .

• Interaction with assembly factors: Investigating how disease-causing mutations affect interactions with assembly factors like NDUFAF1-4, ACAD9, ECSIT, FOXRED1, and TMEM126B can reveal mechanisms of assembly failure in pathological conditions.

• Post-translational modification studies: Analyzing how disease-relevant mutations affect phosphorylation or other modifications of MT-ND4L, especially in light of findings that cAMP-dependent phosphorylation can regulate Complex I activity .

Research has shown that mutations in Complex I components can lead to fatal neurological syndromes, with specific mechanisms including disruption of phosphorylation sites or premature termination of proteins, affecting either activation or assembly of the complex .

What strategies can overcome aggregation issues when working with recombinant MT-ND4L?

The hydrophobic nature of MT-ND4L presents significant challenges related to protein aggregation. Researchers can implement several strategies to address these issues:

• Optimized solubilization conditions:

  • Systematic screening of detergent types, concentrations, and combinations

  • Incorporation of lipids from native mitochondrial membranes

  • Use of amphipathic polymers like amphipols or SMALPs (styrene-maleic acid lipid particles)

• Expression modifications:

  • Fusion with solubility-enhancing tags (MBP, SUMO, Mistic)

  • Co-expression with interaction partners to stabilize protein folding

  • Directed evolution approaches to identify more soluble variants

• Alternative reconstitution approaches:

  • Direct incorporation into nanodiscs or liposomes during or immediately after translation

  • Cell-free expression systems with membrane mimetics present during synthesis

• Analytical techniques for quality assessment:

  • Dynamic light scattering to monitor aggregation state

  • Analytical ultracentrifugation to characterize oligomeric state

  • Thermal shift assays to identify stabilizing conditions

• Computational approaches:

  • Molecular dynamics simulations to identify aggregation-prone regions

  • Structure-guided mutagenesis to reduce aggregation propensity

When implementing these strategies, researchers should systematically document conditions using a decision tree approach, testing combinations of buffers, pH values, salt concentrations, and detergents to identify optimal conditions for their specific experimental needs.

How can researchers accurately assess interactions between MT-ND4L and other Complex I components?

Investigating protein-protein interactions involving hydrophobic membrane proteins like MT-ND4L requires specialized approaches:

• In vitro interaction studies:

  • Microscale thermophoresis (MST) in detergent micelles or nanodiscs

  • Surface plasmon resonance (SPR) with captured liposomes containing MT-ND4L

  • Isothermal titration calorimetry (ITC) adapted for membrane proteins

• Chemical biology approaches:

  • Photo-crosslinking with unnatural amino acids incorporated at specific positions

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map interaction interfaces

  • FRET-based assays using reconstituted components in membrane mimetics

• Cellular interaction studies:

  • Proximity labeling approaches (BioID, APEX) in mitochondria

  • Split complementation assays adapted for the mitochondrial environment

  • Coevolution analysis to predict interaction partners

• Structural approaches:

  • Single-particle cryo-EM of partially assembled complexes

  • Cross-linking mass spectrometry (XL-MS) to identify distance constraints

  • Integrative structural modeling combining multiple data sources

These approaches can help elucidate how MT-ND4L interacts with other components during the assembly process, particularly in the context of the 550 kDa and 815 kDa subcomplexes identified in Complex I assembly studies . Understanding these interactions is crucial for interpreting how mutations might disrupt complex formation and lead to mitochondrial dysfunction.

How do post-translational modifications of MT-ND4L compare across species?

Post-translational modifications (PTMs) of MT-ND4L show interesting variations across species that can provide insights into regulatory mechanisms and evolutionary adaptations:

• Phosphorylation patterns: Research has shown that cAMP-dependent phosphorylation of Complex I components can regulate activity . A systematic analysis of phosphorylation sites in MT-ND4L across species can reveal:

  • Conserved phosphorylation motifs indicating fundamental regulatory mechanisms

  • Species-specific sites that may relate to metabolic adaptations

  • Environmental influences on phosphorylation patterns (e.g., diving mammals vs. terrestrial mammals)

• Other PTMs: Beyond phosphorylation, MT-ND4L may undergo additional modifications:

  • Acetylation patterns that respond to metabolic state

  • Oxidative modifications that may indicate stress responses

  • Ubiquitination or SUMOylation that could regulate turnover

• Regulatory enzymes: Comparing the mitochondrial kinases, phosphatases, and other modifying enzymes across species can provide insights into regulatory divergence. For example, research has identified Ca²⁺-inhibited phosphatases in mitochondria that dephosphorylate Complex I components .

• Functional consequences: Experimental approaches to determine how species-specific PTMs affect:

  • Complex I activity and electron transfer rates

  • Response to environmental stressors

  • Assembly efficiency and subcomplex formation

What molecular clock analyses reveal about the evolution of MT-ND4L in marine mammals?

Molecular clock analyses of MT-ND4L in marine mammals provide valuable insights into evolutionary timescales and selection pressures:

• Divergence time estimates: Using calibrated molecular clocks similar to those applied to other mitochondrial genes in cetaceans (which estimated TMRCAs around 136.7 thousand years ago with 95% CI 85.2-201.1 KYA) , researchers can establish when key changes in MT-ND4L occurred in the Kogia breviceps lineage.

• Substitution rate analysis:

  • MT-ND4L may show different substitution rates compared to other mitochondrial genes

  • The estimated substitution rate for mitochondrial genes in cetaceans (approximately 7.034E-3 substitutions per site per million years) provides a reference point

• Demographic inference: Skyline and skygrid analyses similar to those performed on whale populations can link MT-ND4L evolution to population expansions and contractions:

  • Population expansions beginning 30-35 KYA (skyline) or >80 KYA (skygrid) may correlate with fixation of adaptive variants

  • Bottlenecks may explain reduced diversity in certain regions of the gene

• Adaptive evolution analyses:

  • Branch-site models to detect episodic positive selection

  • Tests for relaxed selection in deep-diving lineages

  • Correlation between diving physiology adaptations and MT-ND4L sequence changes

These analyses can reveal whether MT-ND4L has undergone adaptive evolution specifically in marine mammals like Kogia breviceps, potentially in response to the unique bioenergetic demands of deep diving and oxygen limitation.